BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1311741)

  • 1. A sensitive and specific erythropoietin immunoprecipitation assay: application to pharmacokinetic studies.
    Widness JA; Schmidt RL; Veng-Pedersen P; Modi NB; Sawyer ST
    J Lab Clin Med; 1992 Mar; 119(3):285-94. PubMed ID: 1311741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developmental differences in erythropoietin pharmacokinetics: increased clearance and distribution in fetal and neonatal sheep.
    Widness JA; Veng-Pedersen P; Modi NB; Schmidt RL; Chestnut DH
    J Pharmacol Exp Ther; 1992 Jun; 261(3):977-84. PubMed ID: 1602403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of maternal to fetal transfer of 125I-labelled erythropoietin in sheep.
    Widness JA; Sawyer ST; Schmidt RL; Chestnut DH
    J Dev Physiol; 1991 Mar; 15(3):139-43. PubMed ID: 1658114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of erythropoietin in intact and anephric dogs.
    Fu JS; Lertora JJ; Brookins J; Rice JC; Fisher JW
    J Lab Clin Med; 1988 Jun; 111(6):669-76. PubMed ID: 3373111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic evaluation of two human epidermal growth factors (hEGF51 and hEGF53) in rats.
    Kuo BS; Kusmik WF; Poole JC; Elsea SH; Chang J; Hwang KK
    Drug Metab Dispos; 1992; 20(1):23-30. PubMed ID: 1346992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo 125I-erythropoietin pharmacokinetics are unchanged after anesthesia, nephrectomy and hepatectomy in sheep.
    Widness JA; Veng-Pedersen P; Schmidt RL; Lowe LS; Kisthard JA; Peters C
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1205-10. PubMed ID: 8968342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative pharmacokinetics and distribution of human urinary erythropoietin and recombinant human erythropoietin in rats.
    Kinoshita H; Ohishi N; Kato M; Tokura S; Okazaki A
    Arzneimittelforschung; 1991 Sep; 41(9):1004-7. PubMed ID: 1796912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Damage of tracer erythropoietin results in erroneous estimation of concentration in mouse submaxillary gland.
    Vidal A; Carcagno M; Criscuolo M; Barcelò AC; Alippi RM; Leal T; Bozzini CE
    Exp Hematol; 1993 Feb; 21(2):299-302. PubMed ID: 8425566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Isotope tracer combined with trichloroacetic acid precipitation method for determination of nerve growth factor concentration in mouse plasma].
    Tang G; Jiang G; Zhang Y; Chen L; Wang S
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Jun; 20(3):203-6. PubMed ID: 11367706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of iodine labeled recombinant human erythropoietin.
    Kinoshita H; Ohishi N; Okazaki A
    Arzneimittelforschung; 1991 May; 41(5):568-70. PubMed ID: 1898429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of the pharmacokinetics of small proteins by iodination.
    Bauer RJ; Leigh SD; Birr CA; Bernhard SL; Fang M; Der K; Ihejeto NO; Carroll SF; Kung AH
    Biopharm Drug Dispos; 1996 Dec; 17(9):761-74. PubMed ID: 8968529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impermeability of the ovine placenta to 35S-recombinant erythropoietin.
    Widness JA; Malone TA; Mufson RA
    Pediatr Res; 1989 Jun; 25(6):649-51. PubMed ID: 2740156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A differential pharmacokinetic analysis of the erythropoietin receptor population in newborn and adult sheep.
    Veng-Pedersen P; Chapel S; Al-Huniti NH; Schmidt RL; Sedars EM; Hohl RJ; Widness JA
    J Pharmacol Exp Ther; 2003 Aug; 306(2):532-7. PubMed ID: 12750427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma clearance and tissue distribution of radiolabeled leptin in the chicken.
    McMurtry JP; Ashwell CM; Brocht DM; Caperna TJ
    Comp Biochem Physiol A Mol Integr Physiol; 2004 May; 138(1):27-32. PubMed ID: 15165567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in erythropoietin pharmacokinetics following busulfan-induced bone marrow ablation in sheep: evidence for bone marrow as a major erythropoietin elimination pathway.
    Chapel S; Veng-Pedersen P; Hohl RJ; Schmidt RL; McGuire EM; Widness JA
    J Pharmacol Exp Ther; 2001 Aug; 298(2):820-4. PubMed ID: 11454947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand binding kinetics of a soluble full-length murine erythropoietin receptor.
    Avedissian LS; Poola I; Spivak JL
    Biochem Biophys Res Commun; 1995 Nov; 216(1):62-8. PubMed ID: 7488125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein concentration by precipitation with pyrogallol red prior to electrophoresis.
    Marshall T; Abbott NJ; Fox P; Williams KM
    Electrophoresis; 1995 Jan; 16(1):28-31. PubMed ID: 7737088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pharmacokinetics of lyophilized recombinant human erythropoietin-alpha following single-dose subcutaneous administration in premature newborns.
    Melo AM; Costa MT; Porta V; Vaz FA
    J Matern Fetal Neonatal Med; 2005 Jan; 17(1):55-8. PubMed ID: 15804788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and distribution of recombinant erythropoietin in rats.
    Kinoshita H; Ohishi N; Kato M; Tokura S; Okazaki A
    Arzneimittelforschung; 1992 Feb; 42(2):174-8. PubMed ID: 1610430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of the receptor for erythropoietin in murine erythroleukemia cells after dimethyl sulfoxide treatment.
    Tojo A; Fukamachi H; Saito T; Kasuga M; Urabe A; Takaku F
    Cancer Res; 1988 Apr; 48(7):1818-22. PubMed ID: 2832053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.